Henry Schein Inc. has announced a significant update to its financial reporting practices. On November 16, 2026, the company revealed that it will exclude acquisition-related remeasurement gains from its non-GAAP financial results, starting with its fourth-quarter 2026 earnings. This change is intended to provide a clearer picture of the company’s underlying operating performance and enhance comparability across reporting periods.

The update comes as Henry Schein, a leader in the wholesale medical, dental, and hospital equipment and supplies industry, seeks to improve transparency in its financial reporting. The company also adjusted its fiscal year 2026 non-GAAP diluted earnings per share guidance to a range of $5.42 to $5.48, down from the previous guidance of $5.50 to $5.56. This adjustment reflects the impact of excluding the acquisition-related remeasurement gains.

Background

Henry Schein Inc. is a prominent player in the wholesale medical, dental, and hospital equipment and supplies sector, classified under SIC 5047. The company is listed on the Nasdaq under the ticker HSIC. It has been actively involved in providing healthcare solutions to office-based practitioners, making it a significant entity in the healthcare supply chain.

In recent filings, Henry Schein has demonstrated a commitment to enhancing its financial practices. The latest 8-K filing, dated November 16, 2026, provides insights into the company’s updated financial measures and guidance. This follows several other filings, including a Schedule 13G/A and a 10-Q, indicating ongoing activity and adjustments within the company.

What the Filing Says

The filing details that Henry Schein will begin excluding acquisition-related remeasurement gains from its non-GAAP financial results. The press release states, “Management believes excluding these gains better reflects underlying operating performance and improves comparability across reporting periods.” Furthermore, the company has recast its historical operating income by segment and non-GAAP diluted earnings per share for the fiscal years 2024, 2025, and the first nine months of 2026 to align with this updated presentation.

Impact

This change in financial reporting may impact various stakeholders, including investors and analysts who rely on non-GAAP measures for evaluating the company's performance. By excluding these remeasurement gains, Henry Schein aims to present a more consistent and comparable financial picture, which could influence investor perceptions and decisions. The company’s updated guidance also suggests a more conservative approach to earnings expectations, which may affect market sentiment.

What's Next

The filing does not specify what happens next, but it indicates that Henry Schein intends to apply this treatment to acquisition-related remeasurement gains in its non-GAAP financial measures going forward. Investors and analysts will likely be keen to see how this change affects the company’s future financial disclosures and performance metrics.